Stride (LRN) is down -46.8%, or -$71.92 to $81.61.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRN:
- Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
- Stride price target lowered to $130 from $159 at Morgan Stanley
- Stride price target lowered to $125 from $175 at Canaccord
- Stride’s Long-Term Potential Remains Intact Despite Short-Term Challenges
- Stride downgraded to Market Perform from Outperform at BMO Capital